Peptide Therapy Marketing · Tesamorelin

Tesamorelin Patient Lead Generation for Peptide Clinics

Written byTamerlan Musayev·Founder of PeptideLeads

Tesamorelin patients are usually focused on visceral fat loss, metabolic health, or growth hormone optimization with a specific clinical focus. PeptideLeads delivers these patients to your clinic for $50 per qualified lead. No retainer, we cover all ad spend, and founder Tamerlan Musayev built the system to serve GHRH-focused categories like this one.

The Market Context

Tesamorelin search volume runs between 30,000 and 60,000 monthly in the United States. The audience is predominantly men 40 to 65 with visceral adiposity concerns. It is also searched by patients with HIV-associated lipodystrophy, which is the approved indication. Both segments convert well because the clinical clarity supports easier marketing language.

Why This Works

Tesamorelin protocols run 12 to 26 weeks with potential maintenance cycles. First-year revenue per patient lands between $3,500 and $7,500. At $50 per lead, acquisition economics are strong.

How Our Process Works

We run paid campaigns targeting visceral fat and metabolic intent signals. Qualification captures goals, state, prior treatments, and start timeline. Ad spend covered. $50 per qualified lead.

What Makes Us Different

Tesamorelin is approved for a specific indication, which gives us clearer ad language than most peptides. We know how to use that advantage.

$50 Per Lead. No Retainer. We Cover All Ad Spend.

If your clinic offers Tesamorelin, let's talk.

Book a 30-Minute Call Get Matched

Frequently Asked Questions

Who searches for Tesamorelin?

Visceral fat patients and metabolic health buyers.

What does each lead include?

Full contact info, goals, state, prior treatments, and start timeline.

How many leads per month?

Typically 15 to 35.

Is ad spend covered?

Yes.

Is there a retainer?

No.